Tag Archives: BIO Investor Forum

BIO Investor Forum Celebrates 15th Year with Record Number of Partnering Meetings

bio-4

The 15th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all prior years’ numbers of meetings arranged through the BIO One-on-One Partnering™ system. Both the conference and the partnering system are designed to help investors identify the latest trends and provide biotech innovators an opportunity to secure the funding necessary to bring their technologies to market. This year’s forum brought together over 880 attendees including 240 investors and 155 presenting companies. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Benefiting from Innovative Clinical Trial Designs

bio-14

Clinical trial success rates have been known to be low for some time now, but that does not imply they will remain low forever. As more tools become available to clinical trial sponsors, technical operators and even patients, future clinical success may look nothing like it has over the last decade. Taking steps to change old fashioned protocols were panelist that gathered for today’s panel on clinical trial innovation trends at the BIO Investor Forum Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Small Company with Big Dreams – #BIF16 Fireside Chat with Rachel Haurwitz

BIO_Investor_Forum_RGB_Large

Rachel Haurwitz is young. So is her company. Caribou was founded in 2011 and Haurwitz became the CEO in 2012 when she finished her PhD. In 2014 Haurwitz landed on  FORBES 30 Under 30 list for Science & Healthcare. And then in 2016 she was selected for Fortune magazine’s 2016 “40 Under 40” list, the publication’s annual ranking of the most influential young people in business. During a Fireside Chat today at the BIO Investor Forum, Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Bugs and Drugs: The Promising Microbiome Frontier

BIO_Investor_Forum_RGB_Large

Tuesday at the 2016 BIO Investor Forum wrapped up with a panel discussion on the exciting potential of microbiome research, a relatively new but fast growing field in biopharama. Although still in an early phase, there has been growing excitement over the possibility of bringing new microbiome-derived drugs and therapies to the market.  With promising signs such as the $121M National Microbiome Initiative commitment from the White House, we can anticipate that this field will Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

A Neuroscience Fireside Chat with Ryan Watts at 2016 BIO Investor Forum

bif-logo

The 2106 BIO Investor Forum held a Fireside Chat with Ryan Watts, PhD on Tuesday, October 18 moderated by: Andrew Fein, Managing Director and Senior Healthcare Analyst, Research Division at H.C. Wainwright & Co., LLC. Rachel Lane, PhD, Equity Research, Biotechnology at H.C. Wainwright & Co., LLC Ryan Watts, PhD, is the current Chief Executive Officer at Denali Therapeutics Inc. in addition to being a co-founder and a member of the Board of Directors. Previously, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,